The Latin America heart lung machine market size was estimated at USD 99.72 million in 2024 and is projected to reach USD 150.64 million by 2033, growing at a CAGR of 4.71% from 2025 to 2033. This growth is primarily driven by the increasing prevalence of cardiovascular diseases across the region, which continues to create substantial demand for advanced surgical and life-support technologies. The rising number of cardiac surgeries, including bypass procedures and complex heart operations, has significantly increased the utilization of heart-lung machines that support circulation and oxygenation during surgery. In addition, the growing adoption of advanced cardiopulmonary bypass technologies, which enhance surgical precision and patient safety, is contributing to market expansion. Improvements in healthcare infrastructure, supported by investments in both public and private hospitals, are further enabling wider access to specialized cardiac care services throughout Latin America, thereby supporting industry growth.

In February 2025, Lancet Regional Health Americas reported that in 2021, Latin America and the Caribbean accounted for a growing share of the region’s cardiovascular disease burden, with cardiovascular diseases (CVD) causing 1.1 million deaths in the Americas, while ischemic heart disease and stroke remained the leading causes of mortality. This increasing disease burden highlights the urgent need for advanced cardiac treatment solutions and surgical interventions across the region. As healthcare systems respond to rising patient volumes, hospitals are increasingly adopting sophisticated medical devices, including heart-lung machines, to improve surgical outcomes and manage complex cardiovascular conditions more effectively.

The expansion of heart and lung transplantation programs in Latin America is significantly increasing demand for advanced perfusion and extracorporeal support technologies, such as heart-lung (HL) machines and related consumables. These systems play a critical role in maintaining blood circulation and oxygen supply during transplant procedures, making them essential components of modern cardiac surgery. According to a recent registry, 12,374 heart transplants were conducted at 166 centers across 16 Latin American countries between 1968 and December 2022. This growing procedural volume reflects the steady development and maturation of transplant infrastructure within the region. As transplantation capabilities continue to expand and clinical expertise improves, the demand for reliable perfusion equipment, specialized consumables, and trained perfusion services is expected to increase further, supporting sustained growth of the heart lung machine market in Latin America.

Key Market Trends & Insights:

• The Brazil heart lung machine market accounted for the largest share of 34.68% in Latin America in 2024, underscoring the country’s leading role in the regional cardiac care and medical device landscape. This strong market position is supported by Brazil’s comparatively well-developed healthcare infrastructure, increasing availability of specialized cardiac treatment centers, and a growing number of cardiovascular surgical procedures performed annually. Government initiatives aimed at improving access to advanced medical treatments, along with rising investments in hospital modernization and surgical capabilities, have further strengthened market growth. In addition, the high prevalence of cardiovascular diseases and the presence of experienced healthcare professionals have encouraged the adoption of advanced heart-lung machines across healthcare facilities in the country.

• Based on product, the consumables segment held the largest share in 2024, mainly due to the essential and recurring nature of these products in cardiopulmonary bypass procedures. Consumables such as oxygenators, tubing systems, cannulas, and filters are required for every surgery and must be replaced after each procedure to ensure safety, sterility, and optimal performance. The increasing volume of cardiac surgeries and transplant procedures has resulted in sustained demand for these disposable components, making consumables a major contributor to overall market revenue.

• Based on application, the Coronary Artery Bypass Grafting (CABG) segment held the largest share in 2024, driven by the rising incidence of coronary artery disease and related cardiovascular conditions across the region. CABG procedures rely heavily on heart-lung machines to temporarily take over the function of the heart and lungs during surgery, enabling surgeons to perform complex operations with greater precision. The growing prevalence of lifestyle-related risk factors, including hypertension, diabetes, obesity, and smoking, has contributed to an increasing number of bypass surgeries, thereby supporting the dominance of this application segment.

• Based on end use, the public healthcare institutions segment held the largest share in 2024, reflecting the significant role played by government-funded hospitals in delivering cardiac care services to a large population base. Public healthcare institutions often handle a high volume of surgical procedures due to broader patient access and government-supported treatment programs. Continuous investments in strengthening public healthcare infrastructure, expanding surgical capacities, and improving access to specialized cardiac treatments have driven the adoption of heart-lung machines within these facilities, reinforcing their leading position in the market.

Order a free sample PDF of the Latin America Heart Lung Machine Market Intelligence Study, published by Grand View Research.

Market Size & Forecast:

• 2024 Market Size: USD 99.72 Million

• 2033 Projected Market Size: USD 150.64 Million

• CAGR (2025-2033): 4.71%

• Brazil: Largest market in 2024

Key Companies & Market Share Insights:

Key players operating in the Latin America heart lung machine market are actively undertaking a range of strategic initiatives to strengthen their market presence and expand the reach of their products and services across the region. Companies are focusing on enhancing their distribution networks, improving product accessibility, and introducing technologically advanced solutions tailored to the evolving needs of cardiac care providers. These efforts are aimed at addressing the growing demand for reliable cardiopulmonary support systems while improving clinical outcomes and operational efficiency in hospitals and surgical centers.

Strategies such as expansion activities and partnerships are key in propelling market growth. Market participants are investing in geographic expansion through the establishment of regional offices, service centers, and collaborations with local distributors to improve product availability across emerging healthcare markets. In addition, partnerships with hospitals, research institutions, and healthcare organizations enable companies to strengthen clinical adoption, support training programs for medical professionals, and accelerate the introduction of innovative heart-lung machine technologies. Such collaborative and expansion-focused strategies are contributing significantly to market development by fostering innovation, improving healthcare access, and supporting the overall growth of the Latin America heart lung machine market.

Key Players

• Medtronic

• Terumo Corporation

• LivaNova PLC

• Getinge AB

• Braille Biomedica

• Nipro Corporation do Brasil (NIPRO)

• Surge Cardiovascular

• EUROSETS

• Technowood America Corporation

• Fresenius Medical Care

• MERA (Senko Medical Instrument Mfg. Co., Ltd.)

Explore Horizon Databook – The world's most expansive market intelligence platform developed by Grand View Research.

Conclusion:

The Latin America heart lung machine market is experiencing steady growth, supported by the rising burden of cardiovascular diseases and the increasing number of cardiac and transplant procedures across the region. Expanding healthcare infrastructure, along with growing investments from both public and private healthcare sectors, is improving access to advanced cardiopulmonary technologies and strengthening surgical capabilities in hospitals and specialized cardiac centers.